Elevated serum fibroblast growth factor 23 levels at baseline are linked to a 29% increased risk for diabetic kidney disease, a recent observational study found.
Hosted on MSN15d
FDA approves Ozempic to reduce risks from chronic kidney disease in diabetes patientsOzempic, the blockbuster GLP-1 drug that was originally approved to treat type 2 diabetes, has now also ... “This really means something to the patients,” Gough told CNN. “The impact on not just ...
Hosted on MSN13d
Doctors Can Now Prescribe Ozempic to Reduce Kidney Disease Risks in Diabetes PatientsThis approval makes Ozempic the first GLP-1 treatment for patients with both conditions. Chronic kidney disease is common in ...
Medical Xpress on MSN9d
Yo-yo dieting may significantly increase kidney disease risk in people with type 1 diabetesBody-weight cycling (also known as yo-yo dieting) has been shown to significantly increase the risk of kidney disease in ...
Ozempic, the blockbuster GLP-1 drug that was originally approved to treat type 2 diabetes ... something to the patients," Gough told CNN. "The impact on not just kidney disease but also ...
THE RESULTS ARE PROMISING FOR HEART PATIENTS ... 2 diabetes, has now also been approved by the U.S. Food and Drug Administration to reduce certain risks associated with chronic kidney disease ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback